Quotient : and FAS Diagnostic Group, Inc. sign distribution agreement in the Philippines

Quotient and FAS Diagnostic Group, Inc. have signed a distribution agreement, which will enable FAS Diagnostic Group, Inc. to distribute Alba by Quotient® and MosaiQ® in the Philippines, Southeast Asia. The distribution agreement takes effect immediately.

This strategic partnership reaffirms Quotient's commitment to grow and expand its geographical presence. It will enable both parties to introduce new quality services to the healthcare industry in the Philippines and enhance patient care.

"Quotient's strategic partnership with FAS Diagnostic Group, Inc. is a great example of our commitment to transform patient care worldwide and support the healthcare system through innovative, clinically relevant, accurate, and fast diagnostic solutions," said Manuel O. Méndez, Quotient's CEO.

FAS Diagnostic Group, Inc. is one of the Philippines' local market leaders. Active in the distribution of high-quality laboratory diagnostic solutions, the company partners with global leading IVD players. FAS Diagnostic Group, Inc. has been delivering products to laboratories nationwide for over a decade. The acronym "FAS" stands for "Focused Across Solutions", illustrating their commitment to providing exceptional service.

FAS Diagnostic Group, Inc. is headquartered in Manila with branch offices in Cebu, Iloilo and soon Davao.

FAS Diagnostic Group, Inc. will distribute the Alba by Quotient portfolio - Quotient's range of high-quality blood bank reagents - along with the MosaiQ solution, which aims to facilitate fast and accurate test results in the autoimmune disease field.